CLINICAL RESEARCH
Isolated Elevation in Troponin T After Percutaneous Coronary Intervention Is Associated With Higher Long-Term Mortality
Abhiram Prasad, MD, FRCP, FACC*,*,
Mandeep Singh, MD, FACC*,
Amir Lerman, MD, FACC*,
Ryan J. Lennon, MS ,
David R. Holmes, Jr, MD, FACC* and
Charanjit S. Rihal, MD, FACC*
* Division of Cardiovascular Diseases, Department of Internal Medicine
Section of Biostatistics, Mayo Clinic and Mayo Foundation, Rochester, Minnesota
Manuscript received January 13, 2006;
revised manuscript received April 20, 2006,
accepted April 23, 2006.
* Reprint requests and correspondence: Dr. Abhiram Prasad, Mayo Clinic, 200 First Street SW, Rochester, Minnesota 55905 (Email: prasad.abhiram{at}mayo.edu).
OBJECTIVES: The aim of this study was to evaluate whether, in patients with normal post-procedure CK-MB, an isolated elevation in cardiac troponin T (cTnT) predicts long-term survival.
BACKGROUND: Cardiac troponin T is a sensitive and specific marker of myonecrosis. There is little known about the incidence and prognostic significance of an isolated elevation of cTnT without a rise in creatine kinase (CK)-MB following PCI.
METHODS: We evaluated the outcomes of 1,949 patients from the Mayo Clinic registry who had normal pre-procedure cTnT and CK-MB, required nonemergency percutaneous coronary intervention (PCI), and had normal CK-MB after the procedure.
RESULTS: An elevation in cTnT (cTnT+) was observed in 383 patients (19.6%) (median 0.04 ng/ml, interquartile range 0.03 to 0.06 ng/ml). The TnT+ status was associated with adverse clinical and angiographic characteristics, and multivessel PCI. Over the median follow-up duration of 26 months, mortality (p < 0.001) and the combined rate of death and myocardial infarction (p = 0.004) were significantly higher in cTnT+ patients. Estimated 3-year survival for those with and without cTnT elevation was 86.9% and 93.2%, respectively. By multivariate analysis, an elevation in cTnT after PCI was an independent predictor of increased long-term mortality. A doubling in the post-PCI cTnT was associated with a partial hazard ratio of 1.20 (95% confidence interval 1.02 to 1.40; p = 0.023).
CONCLUSIONS: An isolated minor elevation in cTnT after PCI provides long-term prognostic information regarding mortality and myocardial infarction.
|
Abbreviations and Acronyms
| | CABG = coronary artery bypass graft | | CK-MB = creatine kinase-MB | | CRP = C-reactive protein | | cTnT = cardiac troponin T | | MI = myocardial infarction | | PCI = percutaneous coronary intervention |
|
Related Article
-
Measuring Troponin Elevation After Percutaneous Coronary Intervention: Ready for Prime Time?
- Neal S. Kleiman
J. Am. Coll. Cardiol. 2006 48: 1771-1773.
[Full Text]
[PDF]
This article has been cited by other articles:
|
|
|
|
 
A. S. Jaffe, F. S. Apple, B. Lindahl, C. Mueller, and H. A. Katus
Why all the struggle about CK-MB and PCI?
Eur. Heart J.,
January 11, 2012;
(2012)
ehr502v1.
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. A. Goldstein, B. Maini, S. R. Dixon, E. S. Brilakis, C. L. Grines, D. G. Rizik, E. R. Powers, D. H. Steinberg, K. A. Shunk, G. Weisz, et al.
Detection of Lipid-Core Plaques by Intracoronary Near-Infrared Spectroscopy Identifies High Risk of Periprocedural Myocardial Infarction
Circ Cardiovasc Interv,
October 1, 2011;
4(5):
429 - 437.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. L. Blackshear, D. E. Cutlip, G. S. Roubin, M. D. Hill, P. P. Leimgruber, R. J. Begg, D. J. Cohen, J. F. Eidt, C. R. Narins, R. J. Prineas, et al.
Myocardial Infarction After Carotid Stenting and Endarterectomy: Results From the Carotid Revascularization Endarterectomy Versus Stenting Trial
Circulation,
June 7, 2011;
123(22):
2571 - 2578.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. C. S. Lim, W. J. van Gaal, L. Testa, F. Cuculi, J. R. Arnold, T. Karamitsos, J. M. Francis, S. E. Petersen, J. E. Digby, S. Westaby, et al.
With the "Universal Definition," Measurement of Creatine Kinase-Myocardial Band Rather Than Troponin Allows More Accurate Diagnosis of Periprocedural Necrosis and Infarction After Coronary Intervention
J. Am. Coll. Cardiol.,
February 8, 2011;
57(6):
653 - 661.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. Ganesha Babu, J. Malcolm Walker, D. M. Yellon, and D. J. Hausenloy
Peri-procedural myocardial injury during percutaneous coronary intervention: an important target for cardioprotection
Eur. Heart J.,
January 1, 2011;
32(1):
23 - 31.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Cavallini, P. Verdecchia, S. Savonitto, G. Arraiz, R. Violini, Z. Olivari, P. Rubartelli, S. De Servi, M. Plebani, G. Steffenino, et al.
Prognostic Value of Isolated Troponin I Elevation After Percutaneous Coronary Intervention
Circ Cardiovasc Interv,
October 1, 2010;
3(5):
431 - 435.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. M. Laufer, A. M. A. Mingels, M. H. M. Winkens, I. A. P. G. Joosen, M. W. M. Schellings, T. Leiner, J. E. Wildberger, J. Narula, M. P. Van Dieijen-Visser, and L. Hofstra
The Extent of Coronary Atherosclerosis Is Associated With Increasing Circulating Levels of High Sensitive Cardiac Troponin T
Arterioscler Thromb Vasc Biol,
June 1, 2010;
30(6):
1269 - 1275.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. Cuculi, C. C. S. Lim, and A. P. Banning
Periprocedural myocardial injury during elective percutaneous coronary intervention: is it important and how can it be prevented?
Heart,
May 1, 2010;
96(10):
736 - 740.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. Mangiacapra, E. Barbato, G. Patti, L. Gatto, V. Vizzi, E. Ricottini, A. D'Ambrosio, W. Wijns, and G. Di Sciascio
Point-of-Care Assessment of Platelet Reactivity After Clopidogrel to Predict Myonecrosis in Patients Undergoing Percutaneous Coronary Intervention
J. Am. Coll. Cardiol. Intv.,
March 1, 2010;
3(3):
318 - 323.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. C.S. Lim, W. J. Van Gaal, and A. P. Banning
Periprocedural Myocardial Injury: Not a Benign Entity
J. Am. Coll. Cardiol.,
February 2, 2010;
55(5):
503 - 503.
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Basili, G. Tanzilli, E. Mangieri, V. Raparelli, S. Di Santo, P. Pignatelli, and F. Violi
Intravenous Ascorbic Acid Infusion Improves Myocardial Perfusion Grade During Elective Percutaneous Coronary Intervention: Relationship With Oxidative Stress Markers
J. Am. Coll. Cardiol. Intv.,
February 1, 2010;
3(2):
221 - 229.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Louvard and T. Lefevre
Chapter 18 Coronary bifurcation stenting: state of the art
Oxford Textbook of Interventional Cardiology,
January 1, 2010;
1(1):
med-9780199569083-chapter - med-9780199569083-chapter.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
K Rahimi, A P Banning, A S H Cheng, T J Pegg, T D Karamitsos, K M Channon, S Darby, D P Taggart, S Neubauer, and J B Selvanayagam
Prognostic value of coronary revascularisation-related myocardial injury: a cardiac magnetic resonance imaging study
Heart,
December 1, 2009;
95(23):
1937 - 1943.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. Heusch, P. Kleinbongard, D. Bose, B. Levkau, M. Haude, R. Schulz, and R. Erbel
Coronary Microembolization: From Bedside to Bench and Back to Bedside
Circulation,
November 3, 2009;
120(18):
1822 - 1836.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. J.E. Sattler, J. Herrmann, S. Yun, N. Lehmann, Z. Wang, G. Heusch, S. Sack, R. Erbel, and B. Levkau
High high-density lipoprotein-cholesterol reduces risk and extent of percutaneous coronary intervention-related myocardial infarction and improves long-term outcome in patients undergoing elective percutaneous coronary intervention
Eur. Heart J.,
August 1, 2009;
30(15):
1894 - 1902.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. Testa, W.J. Van Gaal, G.G.L. Biondi Zoccai, P. Agostoni, R.A. Latini, F. Bedogni, I. Porto, and A.P. Banning
Myocardial infarction after percutaneous coronary intervention: a meta-analysis of troponin elevation applying the new universal definition
QJM,
June 1, 2009;
102(6):
369 - 378.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. J. Popma, L. Mauri, C. O'Shaughnessy, P. Overlie, B. McLaurin, A. Almonacid, A. Kirtane, and M. B. Leon
Frequency and Clinical Consequences Associated With Sidebranch Occlusion During Stent Implantation Using Zotarolimus-Eluting and Paclitaxel-Eluting Coronary Stents
Circ Cardiovasc Interv,
April 1, 2009;
2(2):
133 - 139.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Y. Fung, J. Saw, A. Starovoytov, C. Densem, P. Jokhi, S. J. Walsh, R. S. Fox, K. H. Humphries, E. Aymong, D. R. Ricci, et al.
Abbreviated Infusion of Eptifibatide After Successful Coronary Intervention: The BRIEF-PCI (Brief Infusion of Eptifibatide Following Percutaneous Coronary Intervention) Randomized Trial
J. Am. Coll. Cardiol.,
March 10, 2009;
53(10):
837 - 845.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Cuisset, C. Frere, J. Quilici, P.-E. Morange, J.-P. Mouret, L. Bali, P.-J. Moro, M. Lambert, M.-C. Alessi, and J. L. Bonnet
Glycoprotein IIb/IIIa Inhibitors Improve Outcome After Coronary Stenting in Clopidogrel Nonresponders: A Prospective, Randomized Study
J. Am. Coll. Cardiol. Intv.,
December 1, 2008;
1(6):
649 - 653.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Cuisset, M. Hamilos, N. Melikian, E. Wyffels, J. Sarma, G. Sarno, E. Barbato, J. Bartunek, W. Wijns, and B. De Bruyne
Direct Stenting for Stable Angina Pectoris Is Associated With Reduced Periprocedural Microcirculatory Injury Compared With Stenting After Pre-Dilation
J. Am. Coll. Cardiol.,
March 18, 2008;
51(11):
1060 - 1065.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Schiano and P. Gabriel Steg
Measurement and prevention of myocardial injury during percutaneous coronary intervention
Heart,
June 1, 2007;
93(6):
656 - 657.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. E. Cutlip, S. Windecker, R. Mehran, A. Boam, D. J. Cohen, G.-A. van Es, P. Gabriel Steg, M.-a. Morel, L. Mauri, P. Vranckx, et al.
Clinical End Points in Coronary Stent Trials: A Case for Standardized Definitions
Circulation,
May 1, 2007;
115(17):
2344 - 2351.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Isolated cTnT Elevation After PCI
Journal Watch Cardiology,
December 6, 2006;
2006(1206):
3 - 3.
[Full Text]
|
|
|
|
|
|
|
N. S. Kleiman
Measuring Troponin Elevation After Percutaneous Coronary Intervention: Ready for Prime Time?
J. Am. Coll. Cardiol.,
November 7, 2006;
48(9):
1771 - 1773.
[Full Text]
[PDF]
|
|
|
|
